Thus, inhibiting local immune reactions during active inflammation may be significant in managing inflammatory ocular diseases [ 49 ].
← all excerpts
Effectiveness of Topical Cyclosporin-A 0.1% Compared to Combined Topical Cyclosporin-A 0.1% with Topical Sodium Hyaluronate on Interleukin-6 Levels in the Tears of Patients with Dry Eye Disease.
1
—
—